These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36188374)

  • 1. Development and
    Nacher-Soler G; Marteyn A; Barenzung N; Sgroi S; Krause KH; Senn P; Rousset F
    Front Neurol; 2022; 13():993017. PubMed ID: 36188374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nox3-Derived Superoxide in Cochleae Induces Sensorineural Hearing Loss.
    Mohri H; Ninoyu Y; Sakaguchi H; Hirano S; Saito N; Ueyama T
    J Neurosci; 2021 May; 41(21):4716-4731. PubMed ID: 33849947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH Oxidase 3 Deficiency Protects From Noise-Induced Sensorineural Hearing Loss.
    Rousset F; Nacher-Soler G; Kokje VBC; Sgroi S; Coelho M; Krause KH; Senn P
    Front Cell Dev Biol; 2022; 10():832314. PubMed ID: 35273964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-mediated knock-down of NOX3: therapy for hearing loss?
    Rybak LP; Mukherjea D; Jajoo S; Kaur T; Ramkumar V
    Cell Mol Life Sci; 2012 Jul; 69(14):2429-34. PubMed ID: 22562580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
    Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
    Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOX3, a superoxide-generating NADPH oxidase of the inner ear.
    Bánfi B; Malgrange B; Knisz J; Steger K; Dubois-Dauphin M; Krause KH
    J Biol Chem; 2004 Oct; 279(44):46065-72. PubMed ID: 15326186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOX3-TARGETED THERAPIES FOR INNER EAR PATHOLOGIES.
    Rousset F; Carnesecchi S; Senn P; Krause KH
    Curr Pharm Des; 2015; 21(41):5977-87. PubMed ID: 26510434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-tympanic delivery of short interfering RNA into the adult mouse cochlea.
    Oishi N; Chen FQ; Zheng HW; Sha SH
    Hear Res; 2013 Feb; 296():36-41. PubMed ID: 23183031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.
    Mukherjea D; Jajoo S; Whitworth C; Bunch JR; Turner JG; Rybak LP; Ramkumar V
    J Neurosci; 2008 Dec; 28(49):13056-65. PubMed ID: 19052196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.
    Mukherjea D; Jajoo S; Sheehan K; Kaur T; Sheth S; Bunch J; Perro C; Rybak LP; Ramkumar V
    Antioxid Redox Signal; 2011 Mar; 14(6):999-1010. PubMed ID: 20712533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noise-induced changes in expression levels of NADPH oxidases in the cochlea.
    Vlajkovic SM; Lin SC; Wong AC; Wackrow B; Thorne PR
    Hear Res; 2013 Oct; 304():145-52. PubMed ID: 23899412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADPH Oxidase 3: Beyond the Inner Ear.
    Herb M
    Antioxidants (Basel); 2024 Feb; 13(2):. PubMed ID: 38397817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss.
    Rivera T; Sanz L; Camarero G; Varela-Nieto I
    Curr Drug Deliv; 2012 May; 9(3):231-42. PubMed ID: 22283653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss.
    Hajmohammadi Z; Bagher Z; Taghizadeh-Hesary F; Khodadadi M; Masror N; Asghari A; Valipour B; Seifalian A
    Eur J Pharm Biopharm; 2024 Sep; 202():114393. PubMed ID: 38992481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Round window membrane intracochlear drug delivery enhanced by induced advection.
    Borkholder DA; Zhu X; Frisina RD
    J Control Release; 2014 Jan; 174():171-6. PubMed ID: 24291333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.
    Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V
    Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional oriental medicine for sensorineural hearing loss: Can ethnopharmacology contribute to potential drug discovery?
    Castañeda R; Natarajan S; Jeong SY; Hong BN; Kang TH
    J Ethnopharmacol; 2019 Mar; 231():409-428. PubMed ID: 30439402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local drug therapy for inner ear hearing loss].
    Liebau A; Plontke SK
    HNO; 2015 Jun; 63(6):396-401. PubMed ID: 25008276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of noise kurtosis, genetic variations in NOX3 and lifestyle factors with noise-induced hearing loss.
    Zhao T; Wang Y; Li Z; Xu X; Lei S; Huang L; Xu L; Zhang M; Yang L
    Environ Health; 2020 Feb; 19(1):13. PubMed ID: 32014026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochlear protein biomarkers as potential sites for targeted inner ear drug delivery.
    Naples JG; Miller LE; Ramsey A; Li D
    Drug Deliv Transl Res; 2020 Apr; 10(2):368-379. PubMed ID: 31741303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.